- Home
- Publications
- Publication Search
- Publication Details
Title
Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-29
DOI
10.3389/fphys.2021.718783
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The use of Rifaximin in Patients with Cirrhosis
- (2021) Paolo Caraceni et al. HEPATOLOGY
- Pathophysiology of sepsis
- (2021) Pietro Arina et al. Current Opinion in Anesthesiology
- Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
- (2021) Emmanuel Weiss et al. Frontiers in Immunology
- Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction
- (2021) Julia Leonhardt et al. Cellular and Molecular Gastroenterology and Hepatology
- Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis
- (2021) Saravana Ruban Gurusamy et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis
- (2021) Amirhossein Shamsaddini et al. GASTROENTEROLOGY
- Bile acids and their receptors in metabolic disorders
- (2021) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling
- (2020) Lingpeng Zhu et al. FASEB JOURNAL
- Albumin in decompensated cirrhosis: new concepts and perspectives
- (2020) Mauro Bernardi et al. GUT
- Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation
- (2020) Sofia Monteiro et al. GUT
- Cardiodynamic state is associated with systemic inflammation and fatal acute‐on‐chronic liver failure
- (2020) Michael Praktiknjo et al. LIVER INTERNATIONAL
- Regulation of smooth muscle contraction by monomeric non‐RhoA GTPases
- (2020) Bingsheng Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Progression of Stage 2 and 3 Acute Kidney Injury in Patients with Decompensated Cirrhosis and Ascites
- (2020) Florence Wong et al. Clinical Gastroenterology and Hepatology
- Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis
- (2020) Yuly P. Mendoza et al. DIGESTIVE AND LIVER DISEASE
- Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute on Chronic Liver Failure and Death in Patients With Cirrhosis
- (2020) Jasmohan S. Bajaj et al. GASTROENTEROLOGY
- Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
- (2020) Michael Praktiknjo et al. GUT
- Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease
- (2020) John P. Haran et al. GASTROENTEROLOGY
- The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
- (2020) Vicente Arroyo et al. JOURNAL OF HEPATOLOGY
- Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
- (2020) Jonel Trebicka et al. Nature Reviews Gastroenterology & Hepatology
- Microbiome as a therapeutic target in alcohol-related liver disease
- (2019) Shiv K. Sarin et al. JOURNAL OF HEPATOLOGY
- Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis
- (2019) Javier Fernández et al. GASTROENTEROLOGY
- Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
- (2019) Weihua Chen et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Emerging roles of bile acids in mucosal immunity and inflammation
- (2019) Mei Lan Chen et al. Mucosal Immunology
- The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
- (2019) Yoshimitsu Kiriyama et al. Biomolecules
- Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
- (2019) Javier Fernández et al. Clinical Gastroenterology and Hepatology
- Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids
- (2019) Daniele M. Guizoni et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Associations between Dietary Patterns and Bile Acids—Results from a Cross-Sectional Study in Vegans and Omnivores
- (2019) Iris Trefflich et al. Nutrients
- Heart and bile acids – Clinical consequences of altered bile acid metabolism
- (2018) Tharni Vasavan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Bile acid receptors in the biliary tree: TGR5 in physiology and disease
- (2018) Kathleen Deutschmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments
- (2018) Zhimin Liu et al. BMC GASTROENTEROLOGY
- Vascular smooth muscle contraction in hypertension
- (2018) Rhian M Touyz et al. CARDIOVASCULAR RESEARCH
- Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis
- (2018) Macarena Simón-Talero et al. GASTROENTEROLOGY
- Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort
- (2018) Jasmohan S. Bajaj et al. HEPATOLOGY
- Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
- (2018) Katharina Brandl et al. JOURNAL OF HEPATOLOGY
- Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by attenuating Ca 2+ sensitivity via rho kinase pathway
- (2018) Ravirajsinh N. Jadeja et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis
- (2018) Dragos Ciocan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy
- (2017) Ruqi Tang et al. GUT
- Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg
- (2017) Juan P. Arab et al. Hepatology International
- Intestinal fungi contribute to development of alcoholic liver disease
- (2017) An-Ming Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial
- (2017) Nina Kimer et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Biliary bile acids in hepatobiliary injury – What is the link?
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
- (2017) Philipp Schwabl et al. JOURNAL OF HEPATOLOGY
- Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis
- (2017) Marco Di Pascoli et al. JOURNAL OF VASCULAR RESEARCH
- Bile acids and cardiovascular function in cirrhosis
- (2017) Andrei Voiosu et al. LIVER INTERNATIONAL
- Management of cholestatic disease in 2017
- (2017) Elsemieke de Vries et al. LIVER INTERNATIONAL
- Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
- (2017) Francesca Romana Ponziani et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice
- (2016) Niklas Bode et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells
- (2016) Ran Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load
- (2016) L. K. Walsh et al. CLINICAL SCIENCE
- Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial
- (2016) Nina Kimer et al. HEPATOLOGY
- Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart
- (2016) Moreshwar S. Desai et al. HEPATOLOGY
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis
- (2016) Xiaoning Wang et al. JOURNAL OF PROTEOME RESEARCH
- Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis
- (2016) Thomas Horvatits et al. LIVER INTERNATIONAL
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum bile acids in patients with hepatopulmonary syndrome
- (2016) Thomas Horvatits et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
- (2016) Zizhen Gong et al. Oncotarget
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- TGR5, Not Only a Metabolic Regulator
- (2016) Cong Guo et al. Frontiers in Physiology
- Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
- (2016) Dae J Kang et al. Clinical and Translational Gastroenterology
- Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis
- (2015) J. S. Bajaj ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease
- (2015) David S. Goldberg et al. Clinical Gastroenterology and Hepatology
- Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis
- (2015) Elsa Solà et al. DIGESTIVE DISEASES
- Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut
- (2015) Jason M. Ridlon et al. DIGESTIVE DISEASES
- Bile Acids as Hormones: The FXR-FGF15/19 Pathway
- (2015) Steven A. Kliewer et al. DIGESTIVE DISEASES
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery
- (2015) Charles Robb Flynn et al. Nature Communications
- The bile acid TGR5 membrane receptor: From basic research to clinical application
- (2014) Henri Duboc et al. DIGESTIVE AND LIVER DISEASE
- Evidence-Based Treatment of Primary Biliary Cirrhosis
- (2014) Raoul Poupon DIGESTIVE DISEASES
- Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
- (2014) Radha K. Dhiman et al. GASTROENTEROLOGY
- Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions
- (2014) Yasuko Iwakiri et al. JOURNAL OF HEPATOLOGY
- Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades
- (2014) Alan F. Hofmann et al. JOURNAL OF LIPID RESEARCH
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells
- (2013) Taiki Kida et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
- (2013) Josephine A. Grace et al. GASTROENTEROLOGY
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
- (2013) Richard Moreau et al. GASTROENTEROLOGY
- Bile acids induce arrhythmias in human atrial myocardium—implications for altered serum bile acid composition in patients with atrial fibrillation
- (2013) Peter P Rainer et al. HEART
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
- (2013) Len Verbeke et al. HEPATOLOGY
- Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury
- (2012) Jun Pu et al. EUROPEAN HEART JOURNAL
- Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
- (2012) Jiannis Vlachogiannakos et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
- (2012) Karin Dilger et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic Acid in Patients With Chronic Heart Failure
- (2012) Stephan von Haehling et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt
- (2011) Jonel Trebicka et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction
- (2011) L. Moleda et al. GUT
- Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis
- (2011) S. Moller et al. GUT
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- The Role of Lipophilic Bile Acids in the Development of Cirrhotic Cardiomyopathy
- (2010) James H. Zavecz et al. Cardiovascular Toxicology
- Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension
- (2010) Erwin Biecker et al. LIVER INTERNATIONAL
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
- (2009) J. VLACHOGIANNAKOS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vascular hyporesponsiveness to angiotensin II in rats with CCl4-induced liver cirrhosis
- (2009) M. Hennenberg et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
- (2009) Martin Hennenberg et al. LIVER INTERNATIONAL
- Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis
- (2008) Ying-Ying Yang et al. CLINICAL SCIENCE
- Portal Hypertension and Primary Biliary Cirrhosis: Effect of Long-Term Ursodeoxycholic Acid Treatment
- (2008) Pierre–Michel Huet et al. GASTROENTEROLOGY
- Mechanisms of extrahepatic vasodilation in portal hypertension
- (2008) M Hennenberg et al. GUT
- Bile acids: Trying to understand their chemistry and biology with the hope of helping patients
- (2008) Alan F. Hofmann HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started